Paul Sean Little
CIK: 0001749385
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Eledon Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 10, 2025ELDN
Eledon Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
175K shares- - Jan 10, 2025ELDN
Eledon Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
75K shares- - Nov 21, 2024ELDN
Eledon Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
525K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 10, 2025 | ELDN Eledon Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 175,000 | - | - | Direct |
| Jan 10, 2025 | ELDN Eledon Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 75,000 | - | - | Direct |
| Nov 21, 2024 | ELDN Eledon Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 525,032 | - | - | Direct |
1-3 of 3 transactions
About Little Paul Sean
Little Paul Sean (SEC CIK 0001749385) files insider reports with the SEC as Chief Financial Officer of Eledon Pharmaceuticals, Inc. (ELDN).
Signal8 holds 2 ownership filings by Little Paul Sean, all Form 4s, filed between Nov 22, 2024 and Jan 13, 2025. Those filings report 3 transactions, from Nov 21, 2024 to Jan 10, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Little Paul Sean's filings is in IRVINE, CA.
Recent filings by Little Paul Sean
Other insiders filing for Eledon Pharmaceuticals, Inc. (ELDN)
- Gros David-Alexandre C, Chief Executive Officer
- Perrin Steven, President
- McBride John S., Director
- Hillson Jan, Director
- Kirk Allan, Director
- Katkin Keith, Director